Evidence map›Paper›PMID 32959170›Full record

ArticleMolecular neurobiology2021

Quaternary Structure Changes for PrP

Ghazaleh Eskandari-Sedighi, Leonardo M Cortez, Jing Yang, Nathalie Daude, Klinton Shmeit, Valerie Sim, David Westaway

Open access · hybridAbstract read
In one paragraph

Article in Molecular neurobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Creutzfeldt-Jakob disease and other prion diseases.Nature reviews. Disease primers · 2024
    Review
  3. Article
  4. Propagation of PrPCommunications biology · 2023
    Article
  5. Review
  6. Prion-like strain effects in tauopathies.Cell and tissue research · 2023
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ghazaleh Eskandari-SedighiDepartment of Biochemistry, University of Alberta, Edmonton, AB, Canada.
Leonardo M CortezCentre for Prions and Protein Folding Diseases, University of Alberta, 204 Brain and Aging Research Building, Edmonton, AB, T6G 2M8, Canada.
Jing YangCentre for Prions and Protein Folding Diseases, University of Alberta, 204 Brain and Aging Research Building, Edmonton, AB, T6G 2M8, Canada.
Nathalie DaudeCentre for Prions and Protein Folding Diseases, University of Alberta, 204 Brain and Aging Research Building, Edmonton, AB, T6G 2M8, Canada.
Klinton ShmeitCentre for Prions and Protein Folding Diseases, University of Alberta, 204 Brain and Aging Research Building, Edmonton, AB, T6G 2M8, Canada.
Valerie SimCentre for Prions and Protein Folding Diseases, University of Alberta, 204 Brain and Aging Research Building, Edmonton, AB, T6G 2M8, Canada.
David WestawayDepartment of Biochemistry, University of Alberta, Edmonton, AB, Canada. david.westaway@ualberta.ca.ORCID http://orcid.org/0000-0003-1928-4616
University of Alberta · CA

Funding

Canada Foundation for Innovation NIF21633Canada Research Chairs Tier 1CIHR MOP 137094
6 · The paper itself

Abstract

Prion diseases are fatal neurodegenerative diseases in mammals with the unique characteristics of misfolding and aggregation of the cellular prion protein (PrP

Indexed as

Disease ProgressionDown-RegulationAnimalsBiomarkersBrainCell DeathEndopeptidase KGlial Fibrillary Acidic ProteinInflammationMiceMolecular WeightProtein Structure, QuaternaryPrPC ProteinsPrPSc ProteinsScrapieSolubilityBiomarkersEndopeptidase KGlial Fibrillary Acidic ProteinPrPC ProteinsPrPSc ProteinsAsymmetric flow field-flow fractionationNeuronal lossPrion diseasePrP assembliesPrPC downregulationRML

Identifiers

PMID32959170
PMCPMC7695655
OpenAlexW3087134562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.